ProQR to Present at the LEERINK Partners Global Healthcare Conference
Feb 07, 2017 12:01 pm UTC| Business
LEIDEN, the Netherlands, Feb. 07, 2017 -- ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases such...
ProQR to Present at the LEERINK Partners Global Healthcare Conference
Feb 07, 2017 12:01 pm UTC| Business
LEIDEN, the Netherlands, Feb. 07, 2017 -- ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases such...
Feb 07, 2017 12:01 pm UTC| Business
DENVER, Feb. 07, 2017 -- Extraction Oil Gas, Inc. (NASDAQ:XOG), (“Extraction,” or the “Company”), an oil and gas exploration and production company with primary assets in the Wattenberg Field in the Denver-Julesburg...
Feb 07, 2017 12:01 pm UTC| Business
DENVER, Feb. 07, 2017 -- Extraction Oil Gas, Inc. (NASDAQ:XOG), (“Extraction,” or the “Company”), an oil and gas exploration and production company with primary assets in the Wattenberg Field in the Denver-Julesburg...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
Feb 07, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Feb. 07, 2017 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
Feb 07, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Feb. 07, 2017 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today...
Anavex Reports Fiscal First Quarter 2017 Financial Results
Feb 07, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 07, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...